Effects of F-1394, an Acyl-CoA:Cholesterol Acyltransferase (ACAT) Inhibitor, on ACAT Activity in HepG2 Cells and on Hepatic Secretion of Lipids in Triton WR-1339-Induced Hyperlipidemic Rats: Possible Role of Hepatic ACAT in Very Low Density Lipoprotein Secretion-Reference-Cited by-同舟云学术

Effects of F-1394, an Acyl-CoA:Cholesterol Acyltransferase (ACAT) Inhibitor, on ACAT Activity in HepG2 Cells and on Hepatic Secretion of Lipids in Triton WR-1339-Induced Hyperlipidemic Rats: Possible Role of Hepatic ACAT in Very Low Density Lipoprotein Secretion

Published:1998 Issue:3 Volume:76 Page:309-312
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

Aragane Katsumi,Kusunoki Jun,Kitamine Tetsuya,Yamaura Tetsuaki,Ohnishi Haruo

Publisher

Elsevier BV

Subject

Pharmacology

Link

https://www.jstage.jst.go.jp/article/jjp/76/3/76_3_309/_pdf

Reference15 articles.

1. Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents;Sliskovic;Trends Pharmacol Sci,1991

2. Studies on acyl-CoA:cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative;Kusunoki;Jpn J Pharmacol,1995

3. Hypocholesterolemic action and prevention of cholesterol absorption via the gut by F-1394, a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, in cholesterol diet-fed rats;Kusunoki;Jpn J Pharmacol,1995

4. Hypolipidemic action of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, in high fat diet-fed beagle dogs;Kusunoki;Yakugakuzasshi,1997

5. The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by Triton WR-1339;Borenztajn;Biochem J,1976

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice;Molecular Pharmacology;2020-12-31

2. Vicinal diaryl azole-based urea derivatives as potential cholesterol lowering agents acting through inhibition of SOAT enzymes;European Journal of Medicinal Chemistry;2017-04

3. Isoform-specific inhibitors of ACATs: recent advances and promising developments;Future Medicinal Chemistry;2011-12

4. Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation;Current Pharmaceutical Design;2009-09-01

5. Models to Study Atherosclerosis: A Mechanistic Insight;Current Vascular Pharmacology;2009-01-01